objectives To assess adherence outcomes to antiretroviral therapy (ART) of recipients ≥50 years in Soweto, South Africa.
Introduction
Globally, over 40 million people are living with human immunodeficiency virus (HIV) [1] and of these, over 3.6 million are aged 50 or older [2] . Approximately 70% of people living with HIV (PLWHIV) reside in sub-Saharan Africa (SSA) [3] . The latest available data in South Africa (SA) from 2012 reported a HIV prevalence of 13% among 50-to 54-year-olds, decreasing with increasing age [4] .
Adult HIV prevalence has increased over the years, partly because PLWHIV are living longer with antiretroviral therapy (ART) [5, 6] . ART has prolonged life expectancy by delaying disease progression and premature death [5, 6] . In 2012, over half-million (610 000) PLWHIV aged 50 or older were estimated to be residents of South Africa, although less than half of them (260 000) were estimated to be receiving ART [4] . The majority of the PLHIV are enrolled on first-line ART which includes two nucleotide reverse transcriptase inhibitors (NRTIs) and one non-nucleotide reverse transcriptase inhibitor (NNRTI) [7] .
Sustaining high rates of adherence is critical for successful ART treatment and management [5, 6] . Suboptimal adherence results in therapeutic failure and increased risk of drug resistance, viremia, poor health and quality of life [8] [9] [10] . Suboptimal adherence can be due to individual, service, socio-economic and cultural factors [11] [12] [13] [14] [15] [16] . Several recent systematic reviews found that suboptimal adherence to ART is associated with a range of individual, interpersonal, community and structural factors, including stigma and discrimination, forgetting, alcohol/ substance misuse, dissatisfaction/distance to healthcare facility and depression [17] [18] [19] .
In resource-limited settings, adherence to ART has been shown to be high, [14, 20, 21] but adherence differs between age groups [20, 22, 23] . A growing proportion of ART recipients in SSA were over the age of 50 [24] . However, outcomes after starting treatment in this age group (including ART adherence, drug refills and clinic visit) are not well studied, and poorer outcomes such as drug resistance are reported in this age category than in young adults [25, 26] . In the next 30 years, the total number of PLWHIV 50 years or older in SA is likely to triple [27, 28] .
Currently, there is no gold standard measure for evaluating ART adherence. Self-reporting adherence by PLHIV is commonly used, but is subject to recall bias [29] . According to the WHO, drug refill visits and clinic visits are proxy measures of adherence to ART and it is considered associated with ART adherence [30, 31] . In this study, three measures of adherence were used, adherence to pills, adherence to drug refill visits and adherence to clinic visits.
The aim of this study is to assess differences in adherence to ART, drug refill visits and clinic visits by age and factors for suboptimal adherence to ART, drug refills and clinic visits among older HIV-positive individuals receiving ART.
Methods

Study design and data collection
This was a secondary data analysis for a cross-sectional study conducted at two outpatient clinics, a non-governmental organisation (NGO) and a public clinic at the Chris Hani Baragwanath Hospital in Soweto, SA, the largest hospital in Africa [7] . Both clinics used the South African National Antiretroviral Guidelines to provide ART [21] .
In the original study, participants were recruited through posters written in three of the most widely spoken languages in Soweto (English, Sesotho and isiZulu). The posters were put up in waiting areas of health facilities such as pharmacies and clinics. PLHIV who accepted to consent and participate in the study were given information leaflet including 50 SA Rands (approximately US $5) as a transport reimbursement to the health facility to meet with study staff. PLHIV who met the inclusion criteria which included giving consent, being on first-line ART and being 18 years or older were recruited (n = 883) [7] . For this report, only PLHIV 25 years or older are included (n = 878). Adults aged below 25 were excluded because children, adolescents and young adults are established risk groups for poor adherence [18] .
The final interview questionnaire included 59 questions with a total of 210 items. The questionnaire was developed in English and translated into isiZulu and Sesotho. Trained nurses fluent in the three languages conducted the interviews using the questionnaire. The questionnaire was used to gather information on study participants such as socio-demographic status, clinical characteristics, ART adherence and reasons for barriers to adherence through structured interview which lasted about 15 min on average [7, 32] . Questionnaire responses were translated back to English, and data were entered into a database using EpiData [7, 33] .
Three outcomes were investigated in this study: (i) adherence to ART, (ii) adherence to drug refill visits and (iii) adherence to clinic visits. All three questions assessed binary responses [7, 34] . Covariates such as age, sex, total income last month, employment status and other were dichotomised. The different categories of the covariates are listed under Appendix A. Age was dichotomised in these two categories: 25-49 years (<50 years) and ≥50 years.
Statistical analysis
Chi-square and Fisher's exact tests [35] were used to determine whether age is associated with demographic and socio-economic characteristics and ART adherence and whether there is an association between age and selfreported reasons as barriers to adherence (missing pills), missing drug refills and clinic visits.
Subsequent bivariate and multivariate logistic regression analyses [36] were performed to generate odds ratios (OR) including 95% confidence intervals (95%CI) to assess potential relationships between age (exposure) and ART adherence, missing drug refill and missing clinic visits (outcomes). Sex, type of clinic, total income last month and education level were initially considered a priori as potential confounders and were adjusted for in the adjusted regression model analyses. To assess risk factors, logistic regression model using backward elimination was performed for the two age categories (25-49 years and ≥50 years). The P-value was set at 0.10 for dropping variables. All analyses were performed using SPSS software package, version 24 [37] .
Ethical considerations
The study was approved by the research ethics committees at University of the Witwatersrand, Johannesburg, SA (M070721), and the Regional Medical Ethics Board in Stockholm, Sweden (Protocol 2008/3:7) [15] . Participation was voluntary. A written consent form was signed by all participants. Confidentiality and data security was an important part of data collection. 
Results
Characteristics of study participants
Of 878 participants, 73.1% (642/878) were women and 88.3% (775/878) were 25 to 49 years old (median age was 38 for women and 41 for men; P ≤ 0.01). Table 1 summarises the characteristics of study participants. 83% had secondary or tertiary education. PLHIV aged 25-49 had a higher level of education than PLHIV ≥50 years; the proportion of secondary or tertiary education was higher among the younger group (86.5% vs. 60.2%; P < 0.01).
The rate of employment also was higher in PLHIV aged 25 to 49 years (35.1% vs. 20.4%; P < 0.01). Almost all PLHIV had disclosed their HIV status (96.5%) and attended the readiness programme (98.6%); the proportion of attendance to this programme (98.6%
vs. 99%; P = 1.0) was similar in both age groups. HIV disclosure was slightly higher in PLHIV between 25 to 49 years (96.8% vs. 94.2%; P = 0.18).
Adherence to ART was high in both age groups: overall, only 4.8% of PLHIV reported missing their pills last weekend, with no difference in proportion in the two age categories. The proportion of PLHIV reporting missing drug refill visits during the last six months was similar in both age groups (82.8% vs. 83.5%; P = 0.87). The proportion of PLHIV who missed clinic visits during the previous 6 months was higher among 25-to 49-year-old PLHIV than PLHIV aged 50 or older (19.5% vs. 10.7%; P = 0.03).
Association between age and adherence Table 2 summarises the association between ART adherence, drug refill and clinic visits and age. In the unadjusted models, there was no evidence of increased risk of missing pills during the last weekend (OR 0.94, 95%CI 0.36-2.46) and missing drug refill visits during the last six months (OR 1.05, 95%CI 0.60-1.82) and older age. The findings were consistent in the adjusted model: OR for increased risk for missing pills during the last weekend 1.04, 95%CI 0.38-2.83; P = 0.94 and OR for missing drug refill visits 1.08, 95%CI 0.61-1.91; P = 0.80. In the unadjusted and adjusted models, PLHIV ≥50 years were more likely to miss clinic visits during the last six months than PLHIV 25 to 49 years old, (OR 2.02, 95%CI 1.06-3.88; P = 0.03) and (OR 2.15, 95%CI 1.10-4.18; P = 0.03), respectively. ≥50 year and PLHIV 25 to 49 years. For PLHIV z≥50 years, educational level and disclosure status were associated with missing clinic visits during the last six months. PLHIV ≥50 years with no or primary-level education were less likely to have missed a clinic visit during the last six months (OR 0.3; 95%CI 0.1-1.1; P = 0.07) than PLHIV with secondary-or tertiary-level education in the same age category. Older PLHIV who did not disclose their status were less likely to miss clinic visit during the last six months (OR 0.2; 95%CI: 0.0-1.1; P = 0.06). PLHIV <50 years attending the public clinic were less likely to have missed clinic visits during the last 6 months (OR 0.6, 95%CI: 0.4-0.8; P < 0.01) compared to those attending the NGO. PLHIV <50 years who were not employed were more likely to have missed clinic visit during the last six months (OR 1.4, 95%CI: 1.0-2.1; P = 0.06). Reasons for missing clinic visit Table 4 shows the reasons for missing clinic visits during the previous six months. The most common reasons included cost of transportation, being away for work, forgetting and being away on holiday. PLHIV who reported not feeling well and needing rest as a reason for missing clinic visits were more prevalent among PLHIV ≥50 years than PLHIV 25-49 years (1.9% vs. 1.4%; P = 0.66). PLHIV ≥50 years did not list distance/lack of time, refusal of partner, feeling healthy, away for work/ holiday and not believing that ART can help as reasons for missing clinic visits during the last six months.
Factors associated with missing clinic visits
Discussion
In this cross-sectional study among 878 PLHIV receiving first-line ART treatment aged 25 and older, PLHIV 50 years or older were more likely to miss clinic visits, but there was no difference in adherence to ART pills and drug refills during the previous 6 months in the two age categories. Missing a clinic visit among the older PLHIV may be potentially due to financial constraints, as reported by studies in other settings [38] . In this study, older people were more financially vulnerable; the proportion of older PLHIV who earned less than the median income and had no type of employment was higher than the general adult population. A possible explanation may be that older PLHIV who are financially constrained think that the need for clinic visit is not important especially if they adhere to the ART pills. This finding is important because missed clinic visits are associated with incomplete adherence to ART, loss to follow up [39] , decreased CD4 count [40] and increased mortality [41] . Education level and HIV disclosure were factors associated with missing clinic visits during the last six months among PLHIV 50 years or older. Less educated people were less likely to miss clinic visits (P = 0.07) in that age group, consistent with a study from Uganda which found that low socio-economic status was not a predictor of adherence for PLHIV with fully subsidised therapy [39] . The extent to which socio-economic indicators such as education and financial status influence adherence is likely highly context-specific, reflecting trade-offs between competing priorities such as work, family commitments and costs of accessing clinic services. PLHIV 50 years or older that did not disclose their status were less likely to miss clinic visits (P = 0.06). This is contrary to other studies, where status disclosure is associated with improved adherence and retention in care [12, 42] . A study from the United States showed that status disclosure was not significantly associated with ART adherence but was associated with missing clinic visits [43] . Older PLHIV may be less likely to disclose their status possibly due to stigma and myths that older people do not contract HIV due to a lack of sexual activity [26] . Future research is warranted to explore the relationship between HIV status disclosure and adherence among older PLHIV. Additionally, more studies are needed to further understand reasons of missing clinic visits among this population to tailor effective interventions for this group.
At present, there are no universal practical approaches to monitor treatment adherence programmatically [44] , so it might be advantageous to use more than one measure of adherence. Using several adherence measures would increase the sensitivity of identifying PLHIV that do not adhere to ART, thereby minimising misclassification of outcome.
Study limitations and strengths
Specific limitations of this paper include lack of information on other co-morbidities/multi-morbidities except for tuberculosis, which may affect adherence [26] due to polypharmacy and associated increase in pill burden, drug-drug interactions and toxicity. Treating age as a categorical variable rather than a continuous variable may also be a limitation because it results in loss of information and power [45] . Another main limitation is sample size; however, according to our knowledge, little has been published about this topic. A larger sample study will be needed to establish factors associated with adherence to ART including drug refill and clinic visits. The main strength of this study is that it is one of the very few studies investigating adherence to ART and associated risk factors among older HIV patients in SSA. Another strength is that we investigated PLHIV who had been on ART for a long time (median time duration on ART was 39 months); most studies have not considered adherence beyond 24 months after ART initiation [39] .
Conclusion
In summary, this study suggests that missing clinic visits was the only adherence measure that differed between PLHIV aged 25-49 and older; adherence to ART pills and drug refills was the same in both age groups. Missing clinic visits was more common among PLHIV ≥50 years, possibly due to financial vulnerability. Further studies are needed to identify risk factors associated with missing clinic visits and other adherence measures among older PLHIV.
starting to take your ARVs?' Responses included (i) yes and (ii) no.
• TB therapy: Assessed through the question 'Have you been treated for TB before?' with response options (i) yes and (ii) no.
• • 'How did you come to the clinic today?' with six response options: (1) minitaxi, (2) bus, (3) taxi, (4) my own car, (5) walking and (6) other. Subsequently categorised into two: (i) public transport/walking/ other and (ii) own car.
• Number of rooms in household: Assessed through the question 'How many rooms are there in your home?
' with an open-ended response. Dichotomised to (i) 0 to 1 and (ii) 2 or more.
• Number of people in household: Assessed through the question 'Besides you, how many children and adults in total live with you?
' with an open-ended response. Subsequently categorised into two: (i) 0 to 1 and (ii) 2 or more
• 'Is there anyone else in your household who has HIV?' with response options (1) yes, (2) no and (3) do not know.
• 'Besides you, is there anyone else taking ARVs?' with response options (1) yes, (2) no and (3) 
